May 11 (Reuters) - Knight Therapeutics Inc GUD.TO :
* Knight Therapeutics Inc qtrly revenues of $1.8 million, an increase of $682,000 over same period last year
* Knight reports first quarter 2017 results
* Qtrly diluted earnings per share $0.04
* Received full repayment of balance of secured loans to Apicore Inc. and Pro Bono Bio Plc in the quarter Source text for Eikon: ID:nMKWQNZhCa Further company coverage: GUD.TO